Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

3M Innovative Properties Co. acquires and manages intellectual property right. It engages in the acquisition and ownership of the intellectual property rights to the products designed and manufactured by its parent company 3M Corporation. The company was founded on May 10, 1999 and is headquartered in Roseville, MN.

Part of Smith & Nephew plc, T.J. Smith & Nephew Ltd. is a British company located in Hull that manufactures healthcare products. It was founded in 1907. On July 01, 1999 Robinson Healthcare Group Ltd. acquired T.J. Smith & Nephew Ltd. from Smith & Nephew plc for $22.60 million.\nThe company says this about itself: The principal activity of the company is he design. development manufacture and sale of Advanced medical devices.

Kalypto Medical, Inc. manufactured medical devices. Its devices were used to treat diabetic leg ulcers. The firm also provided wound-care products. The company was founded in 2006 and was headquartered in Hastings, MN.

Part of Medtronic Plc, Covidien Pte Ltd. is a Singaporean company located in Singapore that manufactures and supplies medical equipment.

Paul Hartmann AG engages in the production of medical and hygiene products. It operates through the following business segments: Wound Management, Incontinence Management, Infection Management, and Other Group Activities. The Wound Management segment includes wound dressing and products for compression therapy and immobilization. The Incontinence Management segment provides incontinence hygiene, medical records, and products for patient and medical skin care. The Infection Management segment consists of surgery sets, surgical clothing, and surgical examination gloves. The Other Group Activities segment focuses on the areas of cotton wool products, feminine hygiene, baby hygiene, medical consumer goods, medicated and dietary supplements, body care and bath products, and commercial business. The company was founded in 1818 and is headquartered in Heidenheim, Germany.

Vomaris Innovations, a regenerative medical device company, develops microcurrent field generating technologies for the wound care market. It is a regenerative medical device company specializing in microcurrent field generating technologies for the wound care market, announced that eight scientific and clinical abstracts on its flagship product Procellera will be presented at the 26th Annual Symposium on Advanced Wound Care (SAWC) on May 2 - 5, 2013 at the Denver Convention Center. It was founded in 2004 and is based in Tempe, Arizona.

Molnlycke Health Care is a private company headquartered in Southlake,, that manufactures and sells medical devices.

Develops and manufactures products for the ostomy management, advanced chronic and acute wound care and continence care services

PolarityTE is focused on transforming the lives of patients by discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures products from the patient's own tissue and uses the patient's own body to support the regenerative process. From a small piece of healthy autologous tissue, the company creates an easily deployable, dynamic, and self-propagating product designed to regenerate the target tissues. PolarityTE's innovative methods are intended to promote and accelerate growth of the patient's tissues to undergo a form of effective regenerative healing.

ConvaTec Ltd. engages in the development, manufacture and marketing of medical products. It products include the proprietary aquace and hydro fiber technology, connate moldable technology, flexi seal, fecal management system and duoderm dressings. The company was founded in 1978 and is headquartered in Deeside, the United Kingdom.

Southeastern Medical Technologies (SEMT) located in Savannah, Georgia, is an early stage pharmaceutical and medical device research company.

Bluestar Silicones France SAS manufactures and supplies silicones products. The company was founded in 1998 and is headquartered in Saint-Fons, France.

Electrochemical Oxygen Concepts, Inc. engages in the development of wound care technology. The firm offers FDA-cleared Class II, a medical device that provides therapy to difficult-to-heal wounds. It also offers TransCu O2 system, an electrochemical tissue oxygenation and wound monitoring system for use with OxySpur Oxygen Diffusion Dressings as an adjunctive therapy to continuously treat oxygen-compromised wounds. The company was founded by Michael C. Wells in 2007 and is headquartered in San Antonio, TX.

Aatru is focused on wound and damaged skin treatment. The company is developing patent-pending controlled pressure products that, when FDA cleared, promise improved patient care and wellbeing. Through innovative thinking, design, and reduced cost to patient and health care providers, Aatru anticipates compelling returns for investors. The Aatru technology platform includes a portable, wearable completely self-contained, negative pressure bandage, which is not yet FDA-cleared and a separate product designed to treat cosmetically damaged skin. Each device may have the potential to be a market innovator with global market potential. Aatru anticipates a cosmetic solution that leverages the same novel technology of the wound therapy solution, with self-adhering wrinkle treatment tabs and strips that may smooth the appearance of fine lines and wrinkles on the neck and face.

Integrated Healing Technologies (IHT) is a technology-enabled wound care services company that specializes in the delivery of negative pressure wound therapy (“NPWT”) devices and systems. Their mission is to accelerate the healing of patients who suffer from acute and chronic wounds. Their experienced management team has collectively founded sixteen healthcare companies that operated facilities and provided services involving medical imaging, ambulatory surgery, mobile imaging, lithotripsy, prostate cancer treatment and independent practice associations. IHT’s superior Negative Pressure Wound Therapy dressing systems promote healing at the wound bed. IHT’s NPWT systems operate at lower pressures, eradicates biofilm, utilize a non-adherent and antimicrobial dressing, inhibit tissue ingrowth and reduce pain associated with higher pressures and dressing changes. Conversely, their competitor’s foam-based system, patented in 1996, applies greater suction pressures above the wound, results in a high bacterial load, promotes tissue ingrowth, typically require pain medication with dressing changes and increases the risk of foam particulate being left in the wound at dressing change. The primary drivers of wound care products and services are diabetes, cardiovascular disease, obesity, an aging U.S. population and Health Care-Associated Infections. Potential customers include: Hospitals, Long Term Care Facilities, Specialty Wound Care Clinics, Nursing Homes, Home Health Care and Durable Medical Equipment (DME) Providers.